Kodiak Sciences is trading 6.2% down at $84.04 in pre-market on October 27, with no clear company announcement explaining the overnight decline.
- Recent coverage highlights the company’s $350 million at-the-market offering and universal shelf, which raise dilution concerns.
- Kodiak’s SEC filings page lists an October 26 filing, but available evidence does not establish it as the cause of the move.
- Broader index futures were mixed, offering no clear market-wide explanation.